In Vitro and In Vivo Characterisation of a Mucoadhesive Buccal Film Loaded with Doxycycline Hyclate for Topical Application in Periodontitis.
MMP
antibiotic
bioadhesive film
drug delivery
oral cavity
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
08 Feb 2023
08 Feb 2023
Historique:
received:
17
01
2023
revised:
03
02
2023
accepted:
06
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Mucoadhesive films loaded with doxycycline hyclate (Doxy Hyc), consisting of mixtures of hydroxypropylmethyl cellulose (HPMC) E3, K4 and polyacrylic acid (Carbopol 940), were prepared by casting method, aiming to design a formulation intended for application in the oral cavity. The obtained film formulations exhibited a Doxy Hyc content between 7.52 ± 0.42 and 7.83 ± 0.41%, which had adequate mechanical properties for application in the oral cavity and pH values in the tolerance range. The x-ray diffraction studies highlighted the amorphisation of Doxy Hyc in the preparation process and the antibiotic particles present on the surface of the films, identified in the TEM images, which ensured a burst release effect in the first 15 min of the in vitro dissolution studies, after which Doxy Hyc was released by diffusion, the data presenting a good correlation with the Peppas model, n < 0.5. The formulation F1, consisting of HPMC K4 combined with C940 in a ratio of 5:3, the most performing in vitro, was tested in vivo in experimentally-induced periodontitis and demonstrated its effectiveness in improving the clinical parameters and reducing the salivary levels of matrix metalloproteinase-8 (MMP-8). The prepared Doxy Hyc loaded mucoadhesive buccal film could be used as an adjuvant for the local treatment of periodontitis, ensuring prolonged release of the antibiotic after topical application.
Identifiants
pubmed: 36839899
pii: pharmaceutics15020580
doi: 10.3390/pharmaceutics15020580
pmc: PMC9963859
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : CNCS-UEFISCDI, Romania
ID : PN-III-P2-2.1-PED-2019-3664 No.348PED/03.08.2020
Références
J Clin Periodontol. 2018 Jun;45 Suppl 20:S162-S170
pubmed: 29926490
Adv Drug Deliv Rev. 2002 Jan 17;54(1):3-12
pubmed: 11755703
Ther Deliv. 2015;6(5):595-608
pubmed: 26001175
Pharmaceutics. 2022 Feb 28;14(3):
pubmed: 35335917
Arch Oral Biol. 2006 Sep;51(9):794-803
pubmed: 16712777
Antibiotics (Basel). 2019 Dec 30;9(1):
pubmed: 31905889
Periodontol 2000. 2016 Feb;70(1):142-63
pubmed: 26662488
Int J Pharm. 2019 Apr 20;561:244-264
pubmed: 30851391
J Clin Periodontol. 2013 Mar;40(3):227-41
pubmed: 23320860
Periodontol 2000. 2017 Oct;75(1):152-188
pubmed: 28758300
J Oral Pathol Med. 2012 Jan;41(1):61-7
pubmed: 21535163
Materials (Basel). 2021 Aug 27;14(17):
pubmed: 34500962
Adv Mater. 2018 May 7;:e1705328
pubmed: 29736981
Int J Oral Sci. 2019 Oct 1;11(3):28
pubmed: 31570700
Oral Dis. 2011 Apr;17 Suppl 1:73-84
pubmed: 21382140
J Carcinog. 2011;10:23
pubmed: 22013393
Int J Pharm. 2019 Jun 30;565:83-94
pubmed: 31063838
Curr Drug Discov Technol. 2020;17(3):376-386
pubmed: 30806319
Int J Pharm. 2000 Jan 5;193(2):197-203
pubmed: 10606782
Drug Des Devel Ther. 2021 Sep 16;15:3937-3952
pubmed: 34556975
Exp Ther Med. 2015 May;9(5):1813-1818
pubmed: 26136898
Pharmazie. 2009 Mar;64(3):197-201
pubmed: 19348343
AAPS PharmSciTech. 2017 Feb;18(1):93-103
pubmed: 26883262
J Vasc Surg. 2003 Dec;38(6):1376-83
pubmed: 14681644
Exp Suppl. 2012;103:209-79
pubmed: 22642194
AAPS PharmSciTech. 2016 Dec;17(6):1312-1325
pubmed: 26689408
Gels. 2019 Dec 09;5(4):
pubmed: 31835322
J Pharm Biomed Anal. 2003 Nov 24;33(4):667-72
pubmed: 14623592
Biosensors (Basel). 2019 Feb 14;9(1):
pubmed: 30769890
Gels. 2021 Apr 28;7(2):
pubmed: 33924744
J Control Release. 2019 Aug 10;307:393-409
pubmed: 31255689
Molecules. 2021 May 06;26(9):
pubmed: 34066568
Gels. 2017 Jan 24;3(1):
pubmed: 30920503
Dis Mon. 2019 Jun;65(6):164-184
pubmed: 30681961